MERZ NORTH AMERICA, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1908-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.merzusa.com
Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis
- Conditions
- Tinea CrurisTinea Pedis
- Interventions
- Drug: NAFT600 (pediatric)Drug: NAFT600 (adult)Drug: NAFT500 (pediatric)Drug: NAFT500 (adult)
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT01712360
- Locations
- 🇺🇸
Merz Investigative Site #001261, College Station, Texas, United States
🇩🇴Merz Investigative Site #180001, Santo Domingo, Dominican Republic
🇭🇳Merz Investigative Site #504001, San Pedro Sula, Honduras
Study of the Cabochon System for Improvement in the Appearance of Cellulite
- Conditions
- Gynoid Lipodystrophy
- Interventions
- Device: Subcutaneous tissue release with the Cabochon System
- First Posted Date
- 2012-08-24
- Last Posted Date
- 2019-12-10
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT01671839
- Locations
- 🇺🇸
Maryland Laser Skin & Vein Institute, Hunt Valley, Maryland, United States
🇺🇸The Coleman Center for Cosmetic and Dermatologic Surgery, Metairie, Louisiana, United States
🇺🇸SkinCare Physicians, Chestnut Hill, Massachusetts, United States
Belotero Post Approval Study
- Conditions
- Nasolabial Folds
- Interventions
- Device: Belotero®
- First Posted Date
- 2012-07-10
- Last Posted Date
- 2014-07-04
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 117
- Registration Number
- NCT01635855
Mederma to Reduce Appearance of Post Surgical Scars
- Conditions
- Scars
- Interventions
- Other: Mederma N&IOther: Mederma Ultra Gel
- First Posted Date
- 2012-01-05
- Last Posted Date
- 2013-10-24
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01504061
- Locations
- 🇺🇸
Dermatology, Laser, and Vein Specialists of the Carolinas, PLLC, Charlotte, North Carolina, United States
Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis
- Conditions
- Tinea Pedis
- Interventions
- Drug: NAFT-600 (naftin 2 % gel)Drug: Placebo
- First Posted Date
- 2011-02-07
- Last Posted Date
- 2013-09-26
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 860
- Registration Number
- NCT01290341
- Locations
- 🇺🇸
Research Across America, Dallas, Texas, United States
🇺🇸Clinical Research Atlanta, Stockbridge, Georgia, United States
🇺🇸Hudson Dermatology, Evansville, Indiana, United States
Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis
- Conditions
- Tinea Pedis
- Interventions
- Drug: PlaceboDrug: NAFT-600 ( naftin 2 % gel )
- First Posted Date
- 2011-02-03
- Last Posted Date
- 2013-09-26
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 855
- Registration Number
- NCT01289015
- Locations
- 🇺🇸
International Dermatology Research, Inc., Miami, Florida, United States
🇺🇸Northwest Clinical Trials, Boise, Idaho, United States
🇺🇸UCSF Dermatology Research, San Francisco, California, United States
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
- Conditions
- Cervical DystoniaBlepharospasm
- Interventions
- Biological: Xeomin®
- First Posted Date
- 2011-02-01
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 688
- Registration Number
- NCT01287247
- Locations
- 🇺🇸
Site #001979, Virginia Beach, Virginia, United States
🇺🇸Merz Investigative Site #001986, Los Angeles, California, United States
🇺🇸Site # 001972, Chicago, Illinois, United States
Evaluation of Pain With Radiesse® With Lidocaine for Nasolabial Folds
- Conditions
- Nasolabial Folds
- Interventions
- Device: Radiesse® Injectable Dermal Filler without LidocaineDevice: Radiesse® Injectable Dermal Filler with Lidocaine
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT01069354
Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler
- Conditions
- Nasolabial Folds
- Interventions
- Device: Radiesse® Injectable Dermal Filler Mixed with LidocaineDevice: Radiesse® Injectable Dermal Filler without Lidocaine
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2013-04-26
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT01012661
Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color
- Conditions
- Nasolabial Folds
- Interventions
- Device: Radiesse® Injectable Dermal Filler
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2013-04-26
- Lead Sponsor
- Merz North America, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT01012388